Antony and his wife Cynthia Petrello are active philanthropists and have donated $7 million to fund neurological research and have continued to show great personal commitment in leading more fundraising efforts. Cynthia and Tony were blessed with a prematurely born daughter, Carena, at only 24 months weighing only 20 ounces. Immediately after her birth, she was diagnosed with periventricular leukomalacia, a neurological ailment affecting new-borns due to lack of sufficient oxygen and blood in the brain. This made Carena get cerebral palsy and has impaired her motor skills and other developmental delay concerns. This adversity has led the Petrellos to devote all their efforts to seek answers to ensure their child recovers and achieve a normal childhood developmental milestones.

Nevertheless, Carena has been making tremendous growth and has now mastered the art of chewing solid food. Cynthia elucidates that it took her many repetitions for her brain to understand and learn to eat, finally. Cynthia considers this a great miracle.

Tony Petrello, one of the highest paid CEOs and an affiliate of the Texas Children’s Hospital Board of Trustees, clarified that they had explored several pediatric research Centers across the universe in search of answers for their daughter. He further explains that whenever the two heard of a new technological procedure in any part of the world, they will take Carena because as a parent even a two present chance of helping your child walk or talk is enough motivation.

Due to these extensive investigations, Mr. Petrello discovered that there was insufficient knowledge of the condition and most of the research centers focusing on brain study were mainly for adults and none for children. For this reason, the couple found that opportunity at Texas Children’s hospital where they created a Neurological Research Institute for kids to ensure that their child and other people children will reach their full potential.

About Tony Petrello
Antony Petrello, also referred to as Tony, is the President, CEO, and Chairman of Nabors Industries. Nabors Industries is an oil business company that works as a contract driller and offers oil-field services. Tony has worked in several executive positions at the company before moving up the ladder to his current posts. Before joining Nabors Industries, Mr. Petrello was working with the Baker & McKenzie law firm where he was responsible for taxation, international arbitration and general corporate law from 1979 t0 1991.

Tony Petrello has a strong educational background with two degrees. He graduated with a Bachelor’s and Master’s in mathematics from Yale University. Tony was a great math wiz in college, and everyone thought he would pursue a career in maths; however, he shocked many when he decided to go with law. Mr. Petrello attained his Juris Doctor degree at Harvard Law School.

Read More : http://www.thedailybeast.com/articles/2014/05/30/my-college-roommate-is-now-the-richest-ceo-in-america.html

Dr. Shiva Gopal Vasishta is a doctor in New Jersey who specializes in neurology and psychiatry. He studied at Government Medical College and later did his residency at Boston City Hospital. Dr. Shiva has gained almost 40 years of experience in the field with 20 years as a practising doctor and currently works at Eastern Neurodiagnostic Associates but also tends to patients at Kennedy Health System Cherry Hill. Dr. Shiva is one of the doctors committed to find cures to neurological diseases and disorders such as multiple sclerosis (MS).

His practice is one of the few places that conduct transparent transactions when it comes to remitting the medical expenses to the patient’s insurances. The practice accepts most of the insurances companies’ cards and only charges the amounts approved per Medicare policies. The practice’s common language of use is English but uses Spanish too in order to help the patients of Spanish origin.

Dr. Shiva is among the doctors who were involved in the neurological research whose results have been released most recently. The research involved 24 patients of ages 26-52 suffering from relapsing-remitting Multiple Sclerosis. In the research the patients received an autologous hematopoietic cell transplant after their high dosage of high-dose immunosuppressive therapy. 69% of the patients’ conditions stabilized. The conditions improved immensely and they had regained some of their physical abilities. In two of the worst cases the patients died but their deaths were later confirmed to have nothing to do with the experiment although a few caught infections due to their low immune systems.

Even though the findings need further testing, it is certain that the one-time treatment is more effective than the continuous treatment with the MS drugs and this has shone new light to both the patients and the doctors. National institute of health in collaboration with other sponsors such as NIAID carried the research work to completion.